Phytolon closes $23.6m Series B to commercialise FDA-approved fermentation-based natural food colours
The firm has secured $23.6m in Series B funding to bring its fermentation-derived natural colour portfolio to the US market, following FDA approval of the company's first natural colourant, Beetroot Red, as demand for clean-label alternatives to synthetic dyes accelerates